Motamed Cancer Institute
In research, Motamed Cancer Institute stands highest in Life Sciences (#4,774 of 7,800 worldwide), Medicine (#7,003 of 10,443 worldwide) and Health Sciences (#8,179 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 8.3× its share of world research.
- World rank, 2022–2025
- #8,131 of 28,054 · #18,644 all time
- Rank in Iran
- #152 of 301
- Research works
- 557 ▲ 108% vs 2013–17
- Citations
- 10k 18.0 per fractional work
- Top-10% rate
- 21.0% record average 16.5%
- Open access
- 61% world 28%
What is Motamed Cancer Institute known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #4,774 of 7,800 | 20.6% | 61 | #9730 | |
| MedicineField | #7,003 of 10,443 | 16.5% | 84 | #12529 | |
| Health SciencesDomain | #8,179 of 11,982 | 16.5% | 90 | #14843 |
Each strip is that field’s whole ranked pool, with the notch where Motamed Cancer Institute sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#9,730 #4,774
- Medicine#12,529 #7,003
- Health Sciences#14,843 #8,179
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Motamed Cancer Institute specialise in?
Where its research is concentrated relative to its size: Oncology takes 8.3× the share of its output that it takes of world research.
- OncologySubfield · 20.1 works8.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.0×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 4.0×
- Biochemistry, Genetics and Molecular Biology 3.9×
- Immunology and Microbiology 3.7×
- Materials Science 3.7×
- Medicine 2.0×
- Dentistry 2.0×
- Nursing 1.7×
- Chemistry 0.9×
- Neuroscience 0.9×
- Veterinary 0.8×
- Engineering 0.7×
- Energy 0.4×
- Health Professions 0.4×
- Chemical Engineering 0.3×
- Psychology 0.3×
- Economics, Econometrics and Finance 0.2×
- Agricultural and Biological Sciences 0.2×
- Mathematics 0.2×
- Computer Science 0.2×
- Environmental Science 0.1×
- Decision Sciences 0.1×
- Physics and Astronomy 0.1×
- Social Sciences 0.1×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Motamed Cancer Institute?
Ranked on the composite score, Keivan Majidzadeh‐A lead among researchers whose main affiliation is Motamed Cancer Institute.
- 1 Keivan Majidzadeh‐A Iran · #1,231,124 worldwide 26 citations · 41 works
Which keywords describe research at Motamed Cancer Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Biomedical Applications, Cancer, Tissue Engineering, Drug Delivery, Nanocomposites, Nanoparticles, Inflammation and Cancer Therapy.
- Raman Spectroscopy
- Electrochemistry
- Cancer Incidence
- Composites
- Gene Therapy
- Synthesis
- Applications
- Regenerative Medicine
- Angiogenesis
- Regulation
- Tumor Targeting
- Properties
- Metastasis
- Metabolic Syndrome
- Graphene
- Oxidative Stress
- Cancer Therapy
- Drug Delivery
- Tissue Engineering
- Cancer
- Biomedical Applications
- Inflammation
- Nanoparticles
- Nanocomposites
- Chemotherapy
- Breast Cancer
- Gene Expression
- Immunotherapy
- Biomarkers
- Mechanical
- Biogenesis
- Clinical Practice Guidelines
- Radiotherapy
- Carbon Nanotubes
- Toxicity
- Biomaterials
- Survival
- Neoadjuvant Therapy
- Carbon
- Graphene Oxide
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Biomedical Applications18▲ 7.3×24 topics
- Cancer18▲ 6.3×39 topics
- Inflammation16▲ 3.6×52 topics
- Tissue Engineering15▲ 12×12 topics
- Nanoparticles14▲ 5.1×19 topics
- Drug Delivery13▲ 11×12 topics
- Nanocomposites13▲ 7.4×16 topics
- Cancer Therapy10▲ 8.1×18 topics
- Chemotherapy10▲ 6.4×19 topics
- Oxidative Stress9▲ 2.6×39 topics
- Breast Cancer9▲ 17×11 topics
- Graphene9▲ 5.9×9 topics
- Gene Expression8▲ 6.1×13 topics
- Metabolic Syndrome8▲ 4.3×15 topics
- Immunotherapy7▲ 4.7×16 topics
- Metastasis6▲ 8.8×11 topics
- Biomarkers6▲ 4.2×14 topics
- Properties6▲ 36×3 topics
- Mechanical6▲ 53×2 topics
- Tumor Targeting6▲ 16×3 topics
- Biogenesis6▲ 16×3 topics
- Regulation6▲ 5.0×5 topics
- Clinical Practice Guidelines6▲ 4.7×12 topics
- Angiogenesis5▲ 7.6×12 topics
- Radiotherapy5▲ 6.5×10 topics
- Regenerative Medicine5▲ 9.6×6 topics
- Carbon Nanotubes5▲ 7.0×6 topics
- Applications5▲ 8.2×4 topics
- Toxicity5▲ 5.2×9 topics
- Synthesis5▲ 5.9×12 topics
- Biomaterials4▲ 9.0×7 topics
- Gene Therapy4▲ 11×5 topics
- Survival4▲ 15×3 topics
- Composites4▲ 27×2 topics
- Neoadjuvant Therapy4▲ 8.5×5 topics
- Cancer Incidence4▲ 14×3 topics
- Carbon4▲ 30×2 topics
- Electrochemistry4▲ 8.0×2 topics
- Graphene Oxide4▲ 19×2 topics
- Raman Spectroscopy4▲ 9.5×3 topics
Which research topics does Motamed Cancer Institute publish most on?
By volume in 2022–2025: Carbon Nanotubes in Composites, Graphene research and applications, Global Cancer Incidence and Screening and Graphene and Nanomaterials Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Carbon Nanotubes in Composites Materials Chemistry 4 works
- 2 Graphene research and applications Materials Chemistry 3 works
- 3 Global Cancer Incidence and Screening Oncology 3 works
- 4 Graphene and Nanomaterials Applications Biomedical Engineering 3 works
- 5 Advanced biosensing and bioanalysis techniques Molecular Biology 3 works
- 6 Nanoparticle-Based Drug Delivery Biomaterials 3 works
- 7 Cancer Risks and Factors Oncology 3 works
- 8 3D Printing in Biomedical Research Biomedical Engineering 3 works
- 9 Bone Tissue Engineering Materials Biomedical Engineering 3 works
- 10 MicroRNA in disease regulation Cancer Research 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Motamed Cancer Institute's research output changed?
Output in 2018–2022 was 108% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tehran
- University of Tehran
- Tehran University of Medical Sciences
- Tarbiat Modares University
- Amirkabir University of Technology
- Shahid Beheshti University of Medical Sciences
- Sharif University of Technology
- Iran University of Science and Technology
- Shahid Beheshti University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.